Get to know Aclaris better with 10+ real example sentences.
Aclaris in a sentence
Using Aclaris
- In the example corpus, aclaris often appears in combinations such as: aclaris therapeutics, for aclaris, of aclaris.
Context around Aclaris
- Average sentence length in these examples: 18.6 words
- Position in the sentence: 2 start, 8 middle, 1 end
- Sentence types: 11 statements, 0 questions, 0 exclamations
Corpus analysis for Aclaris
- In this selection, "aclaris" usually appears in the middle of the sentence. The average example has 18.6 words, and this corpus slice is mostly made up of statements.
- Around the word, zacks, sankyo and therapeutics stand out and add context to how "aclaris" is used.
- Recognizable usage signals include position in aclaris therapeutics by and shares of aclaris therapeutics in. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "aclaris" sits close to words such as aadi, aakash and aayush, which helps place it inside the broader word index.
Example types with aclaris
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
According to Zacks, “Aclaris Therapeutics, Inc. is a specialty pharmaceutical company. (11 words)
Aclaris Therapeutics () last issued its quarterly earnings results on Tuesday, November 8th. (12 words)
Cantor Fitzgerald also issued estimates for Aclaris Therapeutics’ FY2024 earnings at ($1.59) EPS. (14 words)
Receive News & Ratings for Aclaris Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aclaris Therapeutics and related companies with MarketBeat. (33 words)
Cantor Fitzgerald reiterated an “overweight” rating and issued a $38.00 price objective on shares of Aclaris Therapeutics in a report on Tuesday, February 7th. (25 words)
Finally, Walleye Trading Advisors LLC bought a new position in shares of Aclaris Therapeutics in the second quarter worth about $120,000. (22 words)
Example sentences (11)
Receive News & Ratings for Aclaris Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aclaris Therapeutics and related companies with MarketBeat.
Aclaris Therapeutics () last issued its quarterly earnings results on Tuesday, November 8th.
Cantor Fitzgerald also issued estimates for Aclaris Therapeutics’ FY2024 earnings at ($1.59) EPS.
Cantor Fitzgerald reiterated an “overweight” rating and issued a $38.00 price objective on shares of Aclaris Therapeutics in a report on Tuesday, February 7th.
Russell Investments Group Ltd. lifted its position in Aclaris Therapeutics by 5,265.1% during the first quarter.
Vontobel Holding Ltd. raised its position in Aclaris Therapeutics by 128.8% in the 4th quarter.
Zurcher Kantonalbank Zurich Cantonalbank grew its position in Aclaris Therapeutics by 115.5% during the 4th quarter.
According to Zacks, “Aclaris Therapeutics, Inc. is a specialty pharmaceutical company.
Finally, Walleye Trading Advisors LLC bought a new position in shares of Aclaris Therapeutics in the second quarter worth about $120,000.
In addition, Rigel has product candidates in clinical development with partners BerGenBio ASA, Daiichi Sankyo, Aclaris Therapeutics, and AstraZeneca.
Sofinnova Investments Inc. increased its position in shares of Aclaris Therapeutics by 24.2% during the fourth quarter.
Common combinations with aclaris
These word pairs occur most frequently in English texts:
- aclaris therapeutics 13×
- for aclaris 3×
- of aclaris 3×
- in aclaris 3×